Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Reumatolog Ali Theibich ApS
APS
Active
CVR 39336022
Ringstedgade 208
General medical practice activities · NACE 8621
Est. 2018
4 employees
www.theibich.dk
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,5M
-17% vs 2024
EBITDA margin
7.4%
-80% vs 2024
Equity ratio
83.1%
Financial strength
Net profit 2025
DKK -92K
-143% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
1M
2021
0M
-100%
2022
1M
+100%
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
DKK 1,5M
-17%
EBITDA
DKK 111K
-80%
Net profit
DKK -92K
-143%
Total assets
DKK 1,5M
-18%
Equity
DKK 1,3M
-19%
Employees
4
—
Company information
Legal name
Reumatolog Ali Theibich ApS
CVR number
39336022
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
1. februar 2018
Share capital
DKK 40.000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at udøve speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed.
Contact
Address
Ringstedgade 208
Phone
+4526562578
Email
theibich@gmail.com
Website
www.theibich.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Næstved
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
2M
2021
1M
2022
2M
2023
2M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
1M
2023
1M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
1.803
1.295
1.571
1.808
1.497
Staff expenses
-1.141
-1.187
-959
-1.265
-1.387
EBITDA
662
90
612
543
111
Depreciation & amort.
-117
-187
-187
-226
-191
EBIT
545
-97
424
317
-81
Net financials
-15
-9
-5
-26
-12
Profit before tax
530
-106
420
291
-92
Tax
94
-0
66
74
-0
Net profit
436
-106
353
216
-92
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.777
1.559
1.836
1.856
1.522
Equity
1.295
1.189
1.542
1.558
1.266
Long-term debt
0
0
76
0
0
Short-term debt
482
371
218
298
257
Total debt
482
371
294
298
257
Financial ratios
5-year trend
EBITDA margin
7.4%
This company
15.8%
Market median
-53% vs market
2021
2025
Equity ratio
83.1%
This company
38.2%
Market median
+118% vs market
2021
2025
Return on equity
-7.3%
This company
18.4%
Market median
-140% vs market
2021
2025
Net profit margin
-6.2%
This company
8.1%
Market median
-177% vs market
2021
2025
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
2021
2025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AA
Ali Ahmed Theibich
Chief Executive Officer
Chief Executive Officer
2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Speciallægen Wedian Holding ApS
Company
100%
100%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Speciallægen Wedian Holding ApS
Reumatolog Ali Theibich ApS
(this company)
Board network connections
Board members of Reumatolog Ali Theibich ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Ali Ahmed Theibich
Chief Executive Officer
0 companies